[Antitumor effects of a novel immunomodulator, holding many bioactivities in common with endotoxins, derived from Mycobacterium bovis BCG].
Ikeda-Fujita
T
T
Kotani
S
S
Tsujimoto
M
M
Kato
Y
Y
D000276:Adjuvants, Immunologic / Q000302:isolation & purification / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents; D004731:Endotoxins / Q000494:pharmacology*; D004926:Escherichia coli; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D008813:Mice, Inbred ICR; D009163:Mycobacterium bovis; D009374:Neoplasms, Experimental / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D004731:Endotoxins; D008070:Lipopolysaccharides